ACSS2 and cancer: According to Zhu et al., the ACSS2/KAT2A complex emerges as a central epigenetic regulator in cancer progression, where EGFR activation induces ERK-dependent phosphorylation and the nuclear translocation of ACSS2, enabling this enzymatic complex to catalyze histone lactylation.